No Picture
Trading Ideas

Market Morning: One Country One System, 7000 Boeing Woes, Mideast Tension, California Car Boycott

Beijing Threatens To End One Country Two Systems Hong Kong Status Quo The stage might now be set for a complete Chinese takeover of Hong Kong. According to the South China Morning Post, the Legislative Affairs Commission of the National People’s Congress Standing Committee (NPCSC) criticized the Hong Kong Supreme Court’s decision to declare the […]The post Market Morning: One Country One System, 7000 Boeing Woes, Mideast Tension, California Car Boycott appeared first on Market Exclusive. …read more […]

Newsmakers

Nightfood Ice Cream (OTC: NGTF) Obtains Distribution Commitment from Additional Top-10 Supermarket Chain

TARRYTOWN, NY, Nov. 20, 2019–  Nightfood, Inc. (otcqb:NGTF), the award-winning ice cream company addressing America’s $50 billion-dollar nighttime snacking problem, yesterday received confirmation that sleep-friendly Nightfood ice cream will soon be made available in a […]

No Picture
Trading Ideas

UPDATE 1-Apple starts construction of new $1 billion campus in Texas

Apple Inc said on Wednesday it had started construction of a new campus in Austin, Texas, beside its existing facility where it makes the new MacBook Pro laptops. Apple Chief Executive Officer Tim Cook is set to give a tour of the Texas factory to U.S. President Donald Trump later on Wednesday. The company has come under fire from Trump because it makes most of its products in China. …read more […]

No Picture
Trading Ideas

China's Pinduoduo posts bigger loss as costs surge; shares tumble

The company was started just four years ago but has been described by analysts as a disruptor to the dominance of Alibaba Group Holding Ltd’s Taobao and JD.com Inc over China’s retail sector thanks to its popularity among the country’s rural residents. It added that over 10,000 small and micro merchants were forced to choose between platforms. …read more […]

No Picture
Trading Ideas

UPDATE 1-Bristol-Myers misses main goal of late-stage skin cancer trial

Bristol-Myers Squibb Co said on Wednesday a late-stage trial testing a combination of its cancer drugs missed a main goal of preventing skin cancer from recurring in a certain group of patients, sending its shares down nearly 1%. The company said the trial will continue unchanged as per the recommendation of a data monitoring committee. The trial was testing Bristol-Myers’ drugs Opdivo and Yervoy, against Opdivo alone, in patients with advanced melanoma. …read more […]